Entrar Registro gratuito

RepliCel Life Sciences Quick ratio

Qual é o Quick ratio de RepliCel Life Sciences?

O Quick ratio de RepliCel Life Sciences, Inc. é 0.18

Qual é a definição de Quick ratio?



Liquidez Reduzida é o indicador de liquidez que mede a capacidade de uma empresa de usar seus ativos rápidos para cumprir suas obrigações de curto prazo imediatamente.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio de empresas na Setor Health Care em TSXV em comparação com RepliCel Life Sciences

O que RepliCel Life Sciences faz?

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.

Empresas com quick ratio semelhantes a RepliCel Life Sciences